MSD's new drug combination shows promise in HIV-1 treatment, aiming to offset potential losses from Keytruda's patent ...

As the new cases and related deaths fall in sub-Saharan Africa, the virus is rearing its head elsewhere. What's the cause?

In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an ...

HIV/AIDS cases and deaths have gone up dramatically in the Philippines in the last decade, even though there are drugs to ...

A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...

Gilead stock rated buy for thriving HIV biz, promising oncology pipeline, and long-term growth potential despite volatility.

The human immune deficiency virus (HIV) first entered public consciousness in the early 1980s, after cases of unfamiliar and ...

BAY CITY, MI — A Merrill man already required to register as a sex offender for exposing a child to HIV has been newly ...

A recent study showed that rates of antiretroviral therapy in enrollees living with HIV increased over the years, but women ...

As we mark the holidays, here are a few of the many heroes who are working to build a stronger global health future by ...

The population most affected by HIV has changed in recent years, and public health messaging may not be reaching the ...

Darwin Tenoria first learned about HIV when he was on his deathbed. He was 27 and weighed just 70 pounds. "I died for two minutes and I was revived in the hospital," he remembers. When he woke up ...